DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP

被引：0

作者：

Karschnia, P. ^{[1
,2
]}

Young, J. S. ^{[3
,4
]}

Youssef, G. C. ^{[5
,6
]}

Dono, A. ^{[7
]}

Haeni, L. ^{[8
,9
,10
]}

Sciortino, T. ^{[11
]}

Bruno, F. ^{[12
]}

Juenger, S. T. ^{[13
]}

Teske, N. ^{[1
]}

Dietrich, J. ^{[14
]}

Weller, M. ^{[15
,16
]}

Vogelbaum, M. A. ^{[17
]}

van den Bent, M. ^{[18
]}

Beck, J. ^{[8
]}

Thon, N. ^{[1
]}

Gerritsen, J. K. ^{[3
,4
,19
]}

Hervey-Jumper, S. ^{[3
,4
]}

Cahill, D. P. ^{[20
]}

Chang, S. M. ^{[3
,4
]}

Ruda, R. ^{[12
]}

Bello, L. ^{[11
]}

Schnell, O. ^{[8
,21
]}

Esquenazi, Y. ^{[7
]}

Ruge, M. I. ^{[13
]}

Grau, S. J. ^{[13
,22
]}

Huang, R. Y. ^{[6
,23
]}

Wen, P. Y. ^{[5
,6
]}

Berger, M. S. ^{[3
,4
]}

Molinaro, A. M. ^{[3
,4
]}

Tonn, J. ^{[1
,2
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany

[2] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany

[3] Univ San Francisco, Dept Neurosurg, San Francisco, CA USA

[4] Univ San Francisco, Div Neurooncol, San Francisco, CA USA

[5] Dana Farber Canc Inst, Div Neurooncol, Boston, MA USA

[6] Harvard Med Sch, Boston, MA USA

[7] UT Hlth Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX USA

[8] Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany

[9] Bern Univ Hosp, Inselspital, Dept Neurosurg, Bern, Switzerland

[10] Univ Bern, Bern, Switzerland

[11] Univ Milan, Dept Oncol & Hematooncol, Div Neurooncol, Milan, Italy

[12] Univ Turin, Dept Neurosci, Div Neurooncol, Turin, Italy

[13] Univ Cologne, Dept Neurosurg, Cologne, Germany

[14] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Neurooncol,Dept Neurol, Boston, MA USA

[15] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland

[16] Univ Zurich, Zurich, Switzerland

[17] H Lee Moffitt Canc Ctr & Res Inst, Dept NeuroOncol, Tampa, FL USA

[18] Erasmus MC, Canc Inst, Dept Neurol, Rotterdam, Netherlands

[19] Erasmus MC, Canc Inst, Dept Neurosurg, Rotterdam, Netherlands

[20] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA

[21] Friedrich Alexander Univ Erlangen Nuernberg, Dept Neurosurg, Erlangen, Germany

[22] Marburg Univ, Acad Hosp, Klinikum Fulda, Fulda, Germany

[23] Brigham & Womens Hosp, Div Neuroradiol, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae144.370

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P18.54.B

引用

页码：V111 / V111

页数：1

共 50 条

[41] Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer
Li, Jie
Yi, Jiawen
Hua, Lin
Su, Yanping
Huo, Meirong
Dou, Feifei
Zhai, Zhenguo
Zhu, Min
Zhang, Shu
Zhang, Yuhui
THROMBOSIS RESEARCH, 2021, 208 : 45 - 51
[42] Development and validation of an individualized and weighted myeloma prognostic score system (MPSS) in patients with newly diagnosed multiple myeloma
Yan, Wenqiang
Mao, Xuehan
David, Mery
Xu, Yan
Zou, Dehui
Shaughnessy, John
Anderson, Kenneth
Zhan, Fenghuang
Qiu, Lugui
An, Gang
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S130 - S131
[43] Development and Validation of a Risk Prediction Model for Ischemic Stroke Among Individuals Newly Diagnosed With Cancer
Lun, Ronda
Leentjens, Jenneke
Cerasuolo, Joshua
Kirkwood, David
Kapral, Moira K.
Siegal, Deborah
Sutradhar, Rinku
STROKE, 2024, 55
[44] STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
Lin, Guo-Shi
Yang, Li-Juan
Wang, Xing-Fu
Chen, Yu-Peng
Tang, Wen-Long
Chen, Long
Lin, Zhi-Xiong
MEDICAL ONCOLOGY, 2014, 31 (04)
[45] STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
Guo-Shi Lin
Li-Juan Yang
Xing-Fu Wang
Yu-Peng Chen
Wen-Long Tang
Long Chen
Zhi-Xiong Lin
Medical Oncology, 2014, 31
[46] Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients (vol 93, pg 6703, 2021)
Werfel, Stanislas
Jakob, Carolin E. M.
Borgmann, Stefan
Schneider, Jochen
Spinner, Christoph
Schons, Maximilian
Hower, Martin
Wille, Kai
Haselberger, Martina
Heuzeroth, Hanno
Ruthrich, Maria M.
Dolff, Sebastian
Kessel, Johanna
Heemann, Uwe
Vehreschild, Jorg J.
Rieg, Siegbert
Schmaderer, Christoph
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (11) : 5602 - 5602
[47] Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group.
Ellingson, Benjamin M.
Huang, Raymond Yi-kun
Villanueva-Meyer, Javier
Lim-Fat, Mary Jane
George, Elizabeth
Iorgulescu, Bryan
Young, Geoffrey
Raymond, Catalina
Oughourlian, Talia
Schlossman, Jacob
Gleason, Tyler
Bush, Nancy Ann Oberheim
Wen, Patrick Y.
Cloughesy, Timothy Francis
Chang, Susan Marina
Reardon, David A.
Weller, Michael
Okada, Hideho
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[48] Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials
Wasserfallen, JB
Gold, K
Schulman, KA
Baraniuk, JN
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (01) : 16 - 22
[49] Development and validation of clinical risk score to predict the cardiac rupture in patients with STEMI
Qian, Geng
Jin, Rong-jie
Fu, Zhen-hong
Yang, Yong-qiang
Su, Hong-liang
Dong, Wei
Guo, Jun
Jing, Jing
Guo, Yuan-lin
Chen, Yun-dai
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (04): : 589 - 593
[50] Development of a genetic risk score for coeliac disease and validation in a clinical diagnostic setting
Sharp, S. A.
Jones, S. E.
Kimmitt, R. A.
Weedon, M. N.
Halpin, A.
Wood, A. R.
King, S.
Beaumont, R. N.
Hagopian, W. A.
Turner, J. M.
Oram, R. A.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1627 - 1628

← 1 2 3 4 5 →